HomeReleasesClinical Trial Validates Enzyme Blend for Canine J...
Releases

Clinical Trial Validates Enzyme Blend for Canine Joint Mobility

Clinical Trial Validates Enzyme Blend for Canine Joint Mobility

A double-blind clinical trial has identified Exclzyme Pet™ as a potent tool for canine mobility, with 92% of participating dogs showing measurable improvements in joint health. The study, which assessed pain levels and radiological data, offers new evidence for managing stiffness and discomfort in aging or active animals.

The research, conducted by Specialty Enzymes & Probiotics, evaluated the efficacy of a systemic enzyme blend designed to assist tissue repair and muscle recovery. By tracking metrics such as lameness and joint flexibility, investigators observed a consistent reduction in pain scores across the test group. These findings position the supplement as a scientifically validated option for owners seeking to improve their pets' overall vitality.

Reshma Rathi, Vice President of Specialty Enzymes & Probiotics, noted that the data addresses a widespread concern in the pet supplement market, where joint health remains a primary focus for companion animal care. Based in Chino, California, the manufacturer leverages 45 years of fermentation expertise to produce the blend. Their facilities hold NSF GMP certification, with all finished products undergoing rigorous testing through third-party ISO-17025 laboratories to ensure quality standards.

Share:TelegramXFacebook

Read Also

Comments (0)

Leave a comment

No comments yet. Be the first!